Fusion Conferences: IABCR 2023: 32nd International Association for Breast Cancer Research Conference

Memo

This meeting will involve leaders in the field who study the biological basis of breast cancer, develop approaches for patient stratification, run clinical trials or develop new medicines for patients with breast cancer.  Key Sessions New molecular insight into breast cancer Contemporary models of breast cancer Spatial relationships between molecules and cell types What are the molecular events that drive metastasis Harnessing the immune system  How do we position new treatments in the therapeutic spectrum Confirmed Speakers Cheryl Arrowsmith (University of Toronto)Christine Chaffer (Garvan Institute)Sarat Chandarlapaty (Memorial Sloan Kettering Cancer Center)Christina Curtis (Stanford Medicine)Melissa Davis (Walter and Eliza Hall Institute of Medical Research)Geoffrey Greene (University of Chicago)Theresa Hickey (University of Adelaide)Katherine Hoadley (University of North Carolina at Chapel Hill)Walid Khaled (University of Cambridge)Simon Knott (Cedars-Sinai)Weibo Luo (University of Texas Southwestern Medical Center)Mathieu Lupien (University Health Network)Luca Magnani (Imperial College London)Ciara Metcalfe (Genentech)Bill Muller (McGill University)Senthil Muthuswamy (Dana-Farber / Harvard Cancer Center)Neal Rosen (Memorial Sloan Kettering Cancer Center)Carol Sartorius (University of Colorado Anschutz Medical Campus)Elinor Sawyers (King's College London)Rachel Schiff (Baylor College of Medicine)Violeta Serra (Vall d'Hebron Institute of Oncology)Alex Swabrick (Garvan Institute)Céline Vallot (Institut Curie)Valerie Weaver (University of California, San Francisco)Leonie Young (Royal College of Surgeons in Ireland)Wilbert Zwart (Netherlands Cancer Institute)